Rectal cancer surgery is a vital treatment method for rectal cancer, with anastomosis being a critical step in the surgical process. Traditional manual anastomosis procedures have drawbacks such as complexity, longer anastomosis times, and a higher risk of complications like anastomotic leakage and stenosis. With the continuous development of medical device technology, powered circular staplers have emerged as a new option for rectal cancer surgery.

Recently, research on the application of IntoCare Medical’s ICS Circular Powered Stapler in rectal cancer surgery was published in the prestigious international journal, the “International Journal of Surgery.” The article, titled “Systemic assessment of manual circular stapler versus powered circular stapler for anastomosis in rectal cancer: A large-scale Chinese multicenter prospective cohort study,” was conducted by a collaboration of renowned institutions including Fudan University Shanghai Cancer Center, Changhai Hospital, Peking Union Medical College Hospital, and the First Bethune Hospital of Jilin University. This large-scale, multicenter, prospective cohort study aimed to assess the safety and efficacy of the ICS Circular Powered Stapler in rectal cancer surgery, providing scientific evidence for its clinical application and holding significant academic and clinical guiding value.

The research results indicate that the ICS powered stapler demonstrates significant advantages in rectal cancer surgery:

· The use of ICS in rectal cancer surgeries effectively reduces anastomosis time without compromising safety, offering a promising innovation to enhance the efficacy of rectal cancer surgeries while maintaining patient safety.

· Variations in surgeons’ experiences affect outcomes, but powered circular anastomosis has emerged as a promising solution, ensuring uniform staple formation and reducing manual manipulation.

· Although the primary endpoint, the anastomotic leakage rate, showed no statistically significant difference between the two groups, patients receiving ICS exhibited a trend towards reduced rates of anastomotic leakage one month after surgery.

The publication of this research marks an important breakthrough in the application of the ICS Circular Powered Stapler in rectal cancer surgery and provides strong evidence to promote the intelligent development of colorectal surgery.

IntoCare Medical, a medical technology company with independent research and development as its core competitiveness, always adheres to the philosophy of insight and innovation. The company is committed to providing safer and more effective treatment options for patients. The company’s first product, “The X-in-One” intelligent powered stapling platform, has shown disruptive innovation in the industry since its launch. As an innovative stapler developed independently in China, the ICS Circular Powered Stapler, as an integral part of the platform, will drive progress in the field of colorectal surgery together with the platform, enhancing surgical quality and safety, and offering superior treatment options for rectal cancer patients.

IntoCare Medical will continue to delve into medical technology innovation, providing patients with safer and more effective treatment solutions, and safeguarding life and health with the power of technology, working together to create a better future!